Skip to main content

Vpriv 400 units polvo para solución for infusion

Prescription request online

Prescription request online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

Doctor
5.0(6)

Jorge Correa Bellido

General medicine7 years of experience
Licence no. 464626297

Dr. Jorge Correa Bellido is a Spanish physician who offers online consultations in Spanish and English. He graduated from the University of La Laguna and has a solid background in clinical practice and international research.

Throughout his career, he has participated in various medical and academic projects, including a research fellowship in Spain, where he contributed to evidence-based studies in the field of family medicine. This experience allowed him to broaden his global perspective on healthcare and comprehensive patient care.

Dr. Correa Bellido has worked with several healthcare providers in Spain, focusing particularly on patient-centered care and public health initiatives aimed at communities with limited access to healthcare services.

In addition, he actively participates in international medical conferences and workshops, which allows him to stay up to date with the latest medical advances and collaborate with healthcare professionals from different countries.

Dr. Correa Bellido provides comprehensive care for a wide variety of medical conditions, including:

  • respiratory infections
  • gastrointestinal disorders
  • cardiovascular problems
  • endocrine and metabolic diseases
  • musculoskeletal and dermatological conditions
  • as well as mental health conditions such as anxiety and depression.

He also treats infectious and allergic diseases, general health concerns, and provides guidance on prevention and healthy lifestyle habits.

His services include virtual consultations, diagnosis and management of acute and chronic diseases, prescription renewals, and personalized medical advice.

With a patient-centered approach and a strong commitment to continuous learning, Dr. Correa Bellido provides accessible and high-quality healthcare to patients both in Spain and around the world.

Book a video appointment
€86
This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use VPRIV 400 units powder for solution for infusion

Contents of the leaflet

  1. Introduction
  2. What is VPRIV and what is it used for
  3. What you need to know before you use VPRIV
  4. How to use VPRIV
  5. Possible side effects
  6. Storage of VPRIV
  7. Container Contents and Additional Information

Introduction

Package Leaflet: Information for the User

VPRIV 400units powder for solution for infusion

velaglucerase alfa

Read all of this leaflet carefully before you start using this medicine, because it contains important information for you.

  • Keep this leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
  • If you experience any side effects, talk to your doctor. This includes any possible side effects not listed in this leaflet (see section 4).

Contents of the pack

  1. What is VPRIV and what is it used for
  2. What you need to know before you use VPRIV
  3. How to use VPRIV
  4. Possible side effects
  5. Storage of VPRIV
  6. Contents of the pack and other information

1. What is VPRIV and what is it used for

VPRIV is a long-term enzyme replacement therapy (ERT) for patients with Type 1 Gaucher disease.

Gaucher disease is a genetic disorder caused by a lack of an enzyme or the presence of a defective enzyme, called glucocerebrosidase. When this enzyme is absent or does not work correctly, a substance called glucocerebroside accumulates in the body's cells. The accumulation of this material causes the signs and symptoms that occur in Gaucher disease.

VPRIV contains a substance called velaglucerase alfa that is designed to replace the missing or defective enzyme, glucocerebrosidase, in patients with Gaucher disease.

Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you use VPRIV

Do not useVPRIV

  • if you are severely allergic to velaglucerase alfa or any of the other ingredients of this medicine (listed in section 6).

Warnings and precautions

Talk to your doctor before using VPRIV

  • If you are receiving treatment with VPRIV, you may experience side effects during or after the infusion (see section 4, Possible side effects). These reactions are called infusion-related reactions and may occur as an allergic reaction with symptoms such as nausea, rash, difficulty breathing, back pain, chest discomfort (chest tightness), urticaria, joint pain or headache.
  • In addition to the symptoms of allergic reactions, infusion-related reactions may occur as dizziness, high blood pressure, fatigue, fever, itching, blurred vision or vomiting.

If you experience any of these symptoms, you should tell your doctor immediately.

  • You may be given other medicines to treat or help prevent future reactions. These medicines may include antihistamines, antipyretics and corticosteroids.

Tell your doctor if you have previously experienced an infusion-related reaction with any other ERT for Gaucher disease.

Children

Do not use in children under 4 years of age, as there is no experience with the use of this medicine in this age group.

Using VPRIV withother medicines

Tell your doctor if you are taking, have recently taken or might take any other medicines.

Pregnancy

Gaucher disease may become more active in women during pregnancy and in the weeks following childbirth. Women with Gaucher disease who are pregnant or are planning to become pregnant should talk to their doctor before using this medicine.

Breast-feeding

It is not known whether VPRIV can pass into breast milk. If you are breast-feeding or thinking of breast-feeding, you should talk to your doctor before receiving this medicine. Your doctor will help you decide whether to stop breast-feeding or stop using VPRIV, taking into account the benefits of breast-feeding for the baby and the benefits of VPRIV for the mother.

Talk to your doctor or pharmacist before receiving this medicine.

Driving and using machines

VPRIV has no or negligible influence on the ability to drive and use machines.

VPRIV contains sodium

This medicine contains less than 23 mg of sodium (1 mmol) per vial, which is essentially 'sodium-free'.

3. How to use VPRIV

This medicine should only be used under the supervision of a doctor who has experience in the treatment of Gaucher disease; this person will also determine the dose you should receive.

It must be administered by a doctor or nurse by intravenous infusion. Under the supervision of the doctor, VPRIV can be self-administered (by you or your caregiver) after you have received the relevant training from the doctor and/or nurse. Self-administration should take place in the presence of a responsible adult.

Dose

The recommended dose is 60 units/kg administered every two weeks.

If you are currently receiving treatment for Gaucher disease with another ERT and your doctor wants to switch you to VPRIV, you may initially receive VPRIV at the same dose and frequency as you were receiving the other ERT.

Use in children and adolescents

VPRIV can be given to children and adolescents (from 4 to 17 years of age) at the same dose and frequency as in adults.

Use inelderly patients

VPRIV can be administered to elderly patients (65 years of age or older) at the same dose and frequency as in adults.

Response to treatment

Your doctor will monitor your response to treatment and may adjust the dose (up or down) over time.

If you tolerate the infusions well in the clinic, your doctor or nurse may administer them to you at home.

Administration

VPRIV is supplied as a powder in a vial that is mixed with sterile water and then diluted in a 9 mg/ml (0.9%) sodium chloride solution for infusion before intravenous infusion.

Once prepared, your doctor or nurse will administer the medicine to you by drip into a vein (by intravenous infusion) over a period of 60 minutes.

For self-administration, the dose and infusion rate should not be changed without the consent of the treating doctor.

If you use more VPRIV than you should

If you think you have used more VPRIV than you should, contact your doctor.

If you use less VPRIV than you should

If you think you have used less VPRIV than you should, contact your doctor.

If you forget to use VPRIV

If you miss an infusion of VPRIV, contact your doctor.

If you stop using VPRIV

If you stop using VPRIV, contact your doctor. If you stop using VPRIV, you may experience a return of symptoms. If you have any further questions on the use of this medicine, ask your doctor.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

4. Possible side effects

Like all medicines, VPRIV can cause side effects, although not everybody gets them.

Commonly (may affect up to 1 in 10 people), patients experienced a severe allergic reaction, with difficulty breathing, chest discomfort (chest tightness), nausea, swelling of the face, lips, tongue or throat (anaphylactic/anaphylactoid reactions). Allergic skin reactions such as urticaria, severe rash or itching are also common. If any of these reactions occur, tell your doctor immediately.

Most side effects, including allergic reactions, occurred during or shortly after the infusion. These reactions are called infusion-related reactions.

  • If a severe reaction occurs, your doctor will stop the intravenous infusion immediately and start the appropriate medical treatment.
  • If you are administering the infusion at home and experience a severe infusion-related reaction, including anaphylaxis, stop the infusion immediately, seek urgent medical attentionand contact your doctor.
  • If the reactions are severe and/or there is a loss of effect of this medicine, your doctor may perform a blood test to detect the presence of antibodies that may affect the outcome of your treatment.
  • Your doctor or nurse may decide to continue administering VPRIV even if you experience an infusion-related reaction. Your condition will be closely monitored.

Other infusion-related reactions that occurred very commonly (may affect more than 1 in 10 people) include headache, dizziness, fever/increased body temperature, back pain, joint pain and fatigue, as well as increased blood pressure (reported commonly), blurred vision and vomiting (reported uncommonly). If any of these reactions occur, tell your doctor immediately.

Among the other side effects are:

Very common side effects (may affect more than 1 in 10people):

  • bone pain
  • weakness/loss of strength
  • stomach pain

Common side effects (may affect up to 1 in 10people):

  • prolongation of the time it takes for a wound to stop bleeding that may cause easy bruising, spontaneous bleeding and hematoma formation
  • redness of the skin
  • rapid heartbeat
  • development of antibodies against VPRIV (see section 2)
  • decreased blood pressure

Reporting of side effects

If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of VPRIV

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and label after the letters CAD. The expiry date is the last day of the month stated.

Store in a refrigerator (2°C - 8°C).

Do not freeze.

Keep the vial in the outer carton in order to protect from light.

Reconstituted and diluted solution for infusion:

Use immediately. Do not exceed 24 hours at a temperature of 2°C to 8°C.

Do not use VPRIV if the solution is discolored or if it contains any visible particles.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help to protect the environment.

6. Container Contents and Additional Information

VPRIV Composition

  • The active ingredient is velaglucerase alfa.

Each vial contains 400 units of velaglucerase alfa.

After reconstitution, 1 ml of solution contains 100 units of velaglucerase alfa.

  • The other components are sucrose, sodium citrate dihydrate, citric acid monohydrate, and polysorbate 20 (see section 2 "VPRIV contains sodium").

Product Appearance and Container Contents

20 ml glass vial with a white to off-white powder for solution for infusion.

Packs of 1, 5, or 25 vials.

Only some pack sizes may be marketed.

Marketing Authorization Holder and Manufacturers

Marketing Authorization Holder

Takeda Pharmaceuticals International AG Ireland Branch

Block 2 Miesian Plaza

50-58 Baggot Street Lower

Dublin 2

D02 HW68

Ireland

Manufacturer

Takeda Pharmaceuticals International AG Ireland Branch

Block 2 Miesian Plaza

50-58 Baggot Street Lower

Dublin 2

D02 HW68

Ireland

Shire Pharmaceuticals Ireland Limited

Block 2 & 3 Miesian Plaza

50 – 58 Baggot Street Lower

Dublin 2

Ireland

For further information on this medicinal product, please contact the local representative of the marketing authorization holder:

België/Belgique/Belgien

Takeda Belgium NV

Tel: +32 2 464 06 11

[email protected]

Lietuva

Takeda, UAB

Tel: +370 521 09 070

[email protected]

Text in Bulgarian language with company name Takeda Bulgaria EOOD and phone number +359 2 958 27 36

[email protected]

Luxembourg/Luxemburg

Takeda Belgium NV

Tél/Tel: +32 2 464 06 11

[email protected]

Ceská republika

Takeda Pharmaceuticals Czech Republic s.r.o.

Tel: +420 234 722 722

[email protected]

Magyarország

Takeda Pharma Kft.

Tel.: +36 1 270 7030

[email protected]

Danmark

Takeda Pharma A/S

Tlf: +45 46 77 10 10

[email protected]

Malta

Drugsales Ltd

Tel: +356 21419070

[email protected]

Deutschland

Takeda GmbH

Tel: +49 (0)800 825 3325

[email protected]

Nederland

Takeda Nederland B.V.

Tel: +31 20 203 5492

[email protected]

Eesti

Takeda Pharma OÜ

Tel: +372 6177 669

[email protected]

Norge

Takeda AS

Tlf: +47 800 800 30

[email protected]

Ελλάδα

Τakeda ΕΛΛΑΣ Α.Ε.

Tηλ: +30 210 6387800

[email protected]

Österreich

Takeda Pharma Ges.m.b.H.

Tel: +43 (0) 800-20 80 50

[email protected]

España

Takeda Farmacéutica España S.A

Tel: +34 917 90 42 22

[email protected]

Polska

Takeda Pharma Sp. z o.o.

Tel.: +48223062447

[email protected]

France

Takeda France SAS

Tél: + 33 1 40 67 33 00

[email protected]

Portugal

Takeda Farmacêuticos Portugal, Lda.

Tel: + 351 21 120 1457

[email protected]

Hrvatska

Takeda Pharmaceuticals Croatia d.o.o.

Tel: +385 1 377 88 96

[email protected]

România

Takeda Pharmaceuticals SRL

Tel: +40 21 335 03 91

[email protected]

Ireland

Takeda Products Ireland Ltd

Tel: 1800 937 970

[email protected]

Slovenija

Takeda Pharmaceuticals farmacevtska družba d.o.o.

Tel: + 386 (0) 59 082 480

[email protected]

Ísland

Vistor hf.

Sími: +354 535 7000

[email protected]

Slovenská republika

Takeda Pharmaceuticals Slovakia s.r.o.

Tel: +421 (2) 20 602 600

[email protected]

Italia

Takeda Italia S.p.A.

Tel: +39 06 502601

[email protected]

Suomi/Finland

Takeda Oy

Puh/Tel: 0800 774 051

[email protected]

Κύπρος

A.POTAMITIS MEDICARE LTD

Τηλ: +357 22583333

[email protected]

Sverige

Takeda Pharma AB

Tel: 020 795 079

[email protected]

Latvija

Takeda Latvia SIA

Tel: +371 67840082

[email protected]

United Kingdom (Northern Ireland)

Takeda UK Ltd

Tel: +44 (0) 3333 000 181

[email protected]

Date of Last Revision of this Leaflet: 11/2024.

Other Sources of Information

Detailed information on this medicinal product is available on the European Medicines Agency website: http://www.ema.europa.eu. It also provides links to other websites on rare diseases and orphan medicines.

-------------------------------------------------------------------------------------------------------------------

This information is intended solely for healthcare professionals:

VPRIV is a powder for solution for infusion. It requires reconstitution and dilution and is intended solely for intravenous infusion. VPRIV is for single use only and is administered through a 0.2 or 0.22 µm filter. Discard any unused solution. VPRIV should not be infused with other medications in the same infusion, as compatibility in solution with other products has not been evaluated. The total infusion volume should be administered over a period of 60 minutes.

Use aseptic techniques.

Prepare VPRIV as follows:

  1. Determine the number of vials to reconstitute based on the patient's weight and the indicated dose.
  2. Remove the required number of vials from the refrigerator. Reconstitute each vial using sterile water for injection:

Vial size

Sterile water for injection

400 units

4.3 ml

  1. Once reconstituted, gently mix the vials. Do not shake.
  2. Before dilution, visually inspect the solution in the vials; the solution should be clear to slightly opalescent and colorless; do not use if the solution is discolored or if the presence of foreign particles is observed in suspension.
  3. Remove the calculated volume of the drug from the corresponding number of vials. A remainder of solution will remain in the vial:

Vial size

Extractable volume

400 units

4.0 ml

  1. Dilute the total required volume in 100 ml of 9 mg/ml (0.9%) sodium chloride solution for infusion. Mix gently. Do not shake. Start the infusion within 24 hours after reconstitution.

From a microbiological point of view, use the medicinal product immediately. If not used immediately, the in-use storage times and conditions are the responsibility of the user. Do not exceed 24 hours at a temperature between 2°C and 8°C.

Do not throw the medicinal product down the drain or into the household waste. Eliminate unused medicinal products and all materials that have come into contact with them in accordance with local regulations.

Traceability

In order to improve the traceability of biological medicinal products, clearly record the name and batch number of the administered medicinal product.

Online doctors for VPRIV 400 units powder for solution for infusion

Discuss questions about VPRIV 400 units powder for solution for infusion, including use, safety considerations and whether a prescription is appropriate, subject to medical assessment and local regulations.

Doctor
5.0(6)

Jorge Correa Bellido

General medicine7 years of experience
Licence no. 464626297

Dr. Jorge Correa Bellido is a Spanish physician who offers online consultations in Spanish and English. He graduated from the University of La Laguna and has a solid background in clinical practice and international research.

Throughout his career, he has participated in various medical and academic projects, including a research fellowship in Spain, where he contributed to evidence-based studies in the field of family medicine. This experience allowed him to broaden his global perspective on healthcare and comprehensive patient care.

Dr. Correa Bellido has worked with several healthcare providers in Spain, focusing particularly on patient-centered care and public health initiatives aimed at communities with limited access to healthcare services.

In addition, he actively participates in international medical conferences and workshops, which allows him to stay up to date with the latest medical advances and collaborate with healthcare professionals from different countries.

Dr. Correa Bellido provides comprehensive care for a wide variety of medical conditions, including:

  • respiratory infections
  • gastrointestinal disorders
  • cardiovascular problems
  • endocrine and metabolic diseases
  • musculoskeletal and dermatological conditions
  • as well as mental health conditions such as anxiety and depression.

He also treats infectious and allergic diseases, general health concerns, and provides guidance on prevention and healthy lifestyle habits.

His services include virtual consultations, diagnosis and management of acute and chronic diseases, prescription renewals, and personalized medical advice.

With a patient-centered approach and a strong commitment to continuous learning, Dr. Correa Bellido provides accessible and high-quality healthcare to patients both in Spain and around the world.

Book a video appointment
€86
Doctor
5.0(21)

Nuno Tavares Lopes

General medicine18 years of experience

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies

  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management

  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses

  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment

  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance

  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis

  • Pain management: acute and chronic pain, post-surgical care

  • Public health: prevention, health screenings, long-term monitoring

  • Sick leave (Baixa médica) connected to Segurança Social in Portugal

  • IMT medical certificates for driving licence exchange

Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Book a video appointment
€70
Doctor

Hocine Lokchiri

General medicine21 years of experience

Dr. Hocine Lokchiri is a French consultant with over 20 years of experience in General and Emergency Medicine. He works with adults and children, helping patients with urgent symptoms, infections, sudden health changes and everyday medical concerns that require timely evaluation. His background includes clinical practice in France, Switzerland and the United Arab Emirates, which allows him to navigate different healthcare systems and manage a wide range of conditions with confidence. Patients value his calm, structured approach, clear explanations and evidence-based decision-making.

Online consultations with Dr. Lokchiri are suitable for many situations when someone needs quick medical guidance, reassurance or a clear next step. Common reasons for booking include:

  • fever, chills, fatigue and viral symptoms
  • cough, sore throat, nasal congestion, breathing discomfort
  • bronchitis and mild asthma flare-ups
  • nausea, diarrhoea, abdominal pain, digestive infections
  • rashes, allergic reactions, redness, insect bites
  • muscle or joint pain, mild injuries, sprains
  • headache, dizziness, migraine symptoms
  • stress-related symptoms, sleep disturbances
  • questions about test results and treatment plans
  • management of chronic conditions in stable phases
Many patients reach out when symptoms appear suddenly and cause concern, when a child becomes unwell unexpectedly, when a rash changes or spreads, or when it’s unclear whether an in-person examination is necessary. His emergency medicine background is particularly valuable online, helping patients understand risk levels, identify warning signs and choose safe next steps.

Some situations are not suitable for online care. If a patient has loss of consciousness, severe chest pain, uncontrolled bleeding, seizures, major trauma or symptoms suggesting a stroke or heart attack, he will advise seeking immediate local emergency services. This improves safety and ensures patients receive the right level of care.

Dr. Lokchiri’s professional training includes:

  • Advanced Trauma Life Support (ATLS)
  • Basic and Advanced Cardiac Life Support (BLS/ACLS)
  • Pediatric Advanced Life Support (PALS)
  • Prehospital Trauma Life Support (PHTLS)
  • eFAST and critical care transthoracic echocardiography
  • aviation medicine
He is an active member of several professional organisations, including the French Society of Emergency Medicine (SFMU), the French Association for Emergency Physicians (AMUF) and the Swiss Society of Emergency and Rescue Medicine (SGNOR). In consultations, he works with clarity and precision, helping patients understand their symptoms, possible risks and the safest treatment options.
Book a video appointment
€64
Doctor
4.7(11)

Anastasiia Shalko

General medicine13 years of experience
Licence no. 52891

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate

Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Book a video appointment
€56
Doctor
5.0(1)

Cristina Andrada Brazo

General medicineSleep medicine16 years of experience
Licence no. 264505958

Dr. Cristina Andrada Brazo is a highly experienced Spanish physician with more than 15 years of clinical practice in emergency medicine, urgent care, and clinical neurophysiology. She provides professional online medical consultations for patients across Spain, helping both residents and international visitors receive timely medical advice, diagnosis, treatment recommendations, and electronic prescriptions when clinically appropriate.

As a licensed physician fully integrated with the Spanish electronic prescription system, Dr. Andrada can issue legally valid e-prescriptions following a medical assessment during an online consultation. Whether you need help with an acute illness, prescription renewal, neurological symptoms, or travel-related healthcare, she offers convenient, patient-centered medical care without the need to visit a clinic.

Dr. Andrada combines extensive emergency medicine experience with advanced expertise in neurology, epilepsy, sleep medicine, and headache disorders. Her international clinical background includes several years working in Switzerland, where she collaborated with multidisciplinary teams in emergency departments and neurology services. This experience strengthened her commitment to evidence-based medicine, compassionate communication, and high-quality patient care.

She graduated in Medicine from the University of Seville and completed her residency in Clinical Neurophysiology at Hospital Virgen de la Salud and the National Hospital for Paraplegics in Toledo. She currently works as a Clinical Neurophysiology Specialist at Hospital San Pedro in Logroño.

To further expand her expertise, Dr. Andrada completed several postgraduate qualifications, including Master's degrees in Sleep Physiology and Medicine, Medical Professionalism and Clinical Practice, Epilepsy, and Clinical Management.

Patients appreciate her thorough consultations, practical treatment recommendations, and empathetic approach. She speaks Spanish, French, and Portuguese, allowing her to communicate comfortably with patients from different backgrounds.

Conditions Dr. Cristina Andrada Treats Online

Dr. Andrada provides online consultations for a wide range of common medical conditions, including:

  • Fever, flu, COVID-19 symptoms, sore throat and respiratory infections
  • Sinusitis, bronchitis, cough and seasonal allergies
  • Urinary tract infections (UTIs)
  • Migraine and tension headaches
  • Dizziness and vertigo
  • Epilepsy and seizure follow-up
  • Sleep disorders, including insomnia and circadian rhythm disturbances
  • Heartburn, gastritis, diarrhea and constipation
  • Back pain, muscle injuries and joint pain
  • Minor skin infections and allergic reactions
  • Fatigue and general medical assessment
  • Prescription renewals for appropriate chronic treatments
  • Follow-up consultations after surgery or previous medical treatment
  • Travel medicine advice and preventive healthcare
  • Interpretation of laboratory results and medical reports

If your condition requires urgent in-person assessment or emergency care, Dr. Andrada will advise you on the most appropriate next steps.

Book an Online Consultation

Book a secure online consultation with Dr. Cristina Andrada Brazo through Oladoctor and receive professional medical advice from an experienced Spanish physician without leaving home. Online appointments are available for adults throughout Spain, with fast access to medical care and electronic prescriptions whenever clinically indicated.

Book a video appointment
€56
Doctor
5.0(8)

Lizaveta Trafimchuk Takhvaniuk

DermatologyGeneral medicine10 years of experience
Licence no. 58788

Dr. Lizaveta Trafimchuk Takhvaniuk graduated in Medicine and subsequently specialized in Dermatology and Venereology. She has more than 10 years of clinical experience and is licensed to practice in Spain, where she focuses on the comprehensive diagnosis and treatment of dermatological conditions.

Throughout her education and professional career, Dr. Trafimchuk has gained extensive experience in managing diseases of the skin, hair, and nails, as well as in the diagnosis, treatment, and prevention of sexually transmitted infections (STIs). Her clinical approach is based on evidence-based medicine, combined with personalized care tailored to each patient’s needs.

In her daily practice, she treats a wide range of dermatological conditions, including chronic inflammatory dermatoses such as acne, rosacea, atopic dermatitis, psoriasis, and eczema. She also has experience in treating pigmentation disorders, including melasma, post-inflammatory hyperpigmentation, and dyschromia.

She has developed a particular interest in trichology, treating various types of alopecia, chronic hair loss, and scalp disorders. In addition, she has experience in managing infectious dermatoses of fungal, viral, and bacterial origin, as well as in evaluating benign and suspicious skin lesions, with referral to specialized care when necessary.

With a strong interest in a comprehensive approach to skin health, she also treats scars, post-procedural skin changes, and conditions related to hormonal factors and aging, including those associated with pregnancy, menopause, and age-related skin changes.

Thanks to her experience and continuous professional development, Dr. Trafimchuk provides high-quality medical care that is professional, confidential, and aligned with modern dermatology standards.

Book a video appointment
€72

Frequently Asked Questions

VPRIV 400 units powder for solution for infusion requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.

The active ingredient in VPRIV 400 units powder for solution for infusion is velaglucerase alfa. This information helps identify medicines with the same composition but different brand names.

VPRIV 400 units powder for solution for infusion is manufactured by Takeda Pharmaceuticals International Ag Ireland Branch. Pharmacy brands and packaging may differ depending on the distributor.

Doctors such as Family doctors, Endocrinologists, Gastroenterologists, Oncologists, Sports medicine specialists, General medicine doctors, Lactation medicine doctors, Intensive care physicians may assess whether VPRIV 400 units powder for solution for infusion is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.

The prescription is issued by a doctor after assessing your health. In Spain, VPRIV 400 units powder for solution for infusion is then dispensed in pharmacies with that prescription. An online consultation does not guarantee that a prescription will be issued: the decision always rests with the doctor.

To request an assessment, you can use Oladoctor:

Other medicines with the same active substance (velaglucerase alfa) include ALDURAZYME, 100 U/mL Concentrate for Infusion Solution, BRINEURA 150 MG SOLUTION FOR INFUSION, CEREZYME 400 units powder for concentrate for infusion solution. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media